From capacity to complexity: Ruth Foran on leading NIRAS Ireland's life sciences practice
Ruth Foran has spent more than six years at NIRAS helping Ireland's leading pharmaceutical and biotech clients across the full project lifecycle, from concept development through to commissioning and handover. As Vice President and Business Unit Director at NIRAS Ireland, she leads a team that combines deep local knowledge with the broader capabilities of NIRAS's international network.
Since joining in 2019, Ruth has watched the Irish life sciences market shift from rapid capacity expansion towards a more considered balance of operational performance, digitalisation, and energy efficiency - shaped by the realities of brownfield sites and ageing assets.
In this interview, Ruth reflects on what has changed in the Irish market, how NIRAS approaches complex projects end to end, and what she sees as the priorities for her team, and for the sector in the years ahead.
How has your perspective on the Irish life sciences market evolved since 2019?
The Irish life sciences sector is well established. When I joined NIRAS in 2019, the primary focus was capacity expansion and growth.
Today, the market feels more nuanced. Clients are no longer just focused on building new facilities at pace; they're balancing speed with resilience and reliability, sustainability, and lifecycle performance.
The sector is thinking much more strategically about operational excellence, digitalisation, and decarbonisation. Ireland remains incredibly attractive for global life sciences investment - and success increasingly depends on smart, integrated engineering and advisory support rather than pure delivery capacity.
What drew you to engineering consultancy in life sciences, and what keeps you motivated?
Life sciences sits at a unique intersection of engineering, science, and societal impact. What drew me in was the opportunity to work on technically complex projects that genuinely matter - facilities that produce medicines and therapies people rely on every day.
What keeps me motivated is the pace of change. Regulations evolve, technologies advance, product portfolios grow, and client expectations rise. Helping our clients navigate that complexity and make well-informed decisions is genuinely rewarding.
How do you and your team approach a complex life sciences project end to end?
Our starting point is always the client's business objectives, and how these translate into robust engineering solutions. Early on, we focus on clear scope definition, risk identification, and realistic programme and cost planning. That upfront clarity is critical to alignment and project success.
As projects move through design and delivery, our approach is highly collaborative. We integrate engineering, CQV, and project management expertise so that decisions made in design support construction and commissioning, enabling a smooth transition to operations.
The sector is thinking much more strategically about operational excellence, digitalisation, and decarbonisation...
...and success increasingly depends on smart, integrated engineering and advisory support rather than pure delivery capacity.
How does NIRAS' local presence and international network benefit clients in practice?
Locally, our teams understand the regulatory landscape, planning environment, contractor market, and client operating models. Being part of an international network means we can simultaneously draw on specialist expertise and lessons learned from comparable projects across Europe, the US, and beyond.
In practice, that might mean bringing in niche process expertise from Denmark, regulatory knowledge from the US market, or digital and sustainability insights from the wider NIRAS organisation, all while maintaining a single, locally accountable team for the client.
What do multinational life sciences clients in Ireland need most right now?
Clients want partners who can help them extract more value from existing assets, not just build new ones. That means brownfield upgrades, debottlenecking, digital transformation, and energy-driven modifications, all with minimal disruption to live operations.
There's also growing demand for partners who tackle energy efficiency and carbon reduction through concrete, engineering-led solutions.
What trends are you watching most closely in the life sciences market?
We're seeing more focus on flexibility and resilience: Facilities designed to accommodate multiple products, operational efficiency, and measurable sustainability targets. There's also increased emphasis on supply chain security and local manufacturing capability.
Sustainability targets around energy, water, and carbon are now firmly embedded in engineering decision-making. Digitalisation is equally prominent, from digital construction through to smart validation approaches.
Read more about our offerings in Ireland and globally: https://www.niras.com/offices/ireland/
We’re seeing more focus on flexibility and resilience: Facilities designed to accommodate multiple products, evolving modalities, and sustainability targets. There’s also increased emphasis on supply chain security and local manufacturing capability.
Reach out:
